CRVO logo

CRVO
CervoMed Inc

22,362
Mkt Cap
$79.71M
Volume
140,037.00
52W High
$16.94
52W Low
$1.80
PE Ratio
-3.11
CRVO Fundamentals
Price
$9.01
Prev Close
$8.62
Open
$8.65
50D MA
$7.79
Beta
1.04
Avg. Volume
102,320.96
EPS (Annual)
-$2.02
P/B
3.21
Rev/Employee
$649,198.27
Loading...
Loading...
CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. CervoMed, Inc. was founded in1995 and is headquartered in Boston, MA.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
15

Frequently Asked Questions

What is Market Cap of CervoMed Inc?
What is the 52-week high for CervoMed Inc?
What is the 52-week low for CervoMed Inc?
What is CervoMed Inc stock price today?
What was CervoMed Inc stock price yesterday?
What is the PE ratio of CervoMed Inc?
What is the Price-to-Book ratio of CervoMed Inc?
What is the 50-day moving average of CervoMed Inc?
How many employess does CervoMed Inc has?

Latest CRVO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.